Source-linked trial list

The registrations behind this number.

Verify the exact trial registrations behind a company, intervention, programme or topic count.

Exact trial list

3 matching trial registrations

Intervention Busulfan

Showing 1–3 of 3. Every record below meets all the filters shown above.

RecruitingNCT05463133

Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease (CGD) With an Alemtuzumab, Busulfan and TBI-based Conditioning Regimen Combined With Cytokine (IL-6, +/- IFN-gamma) Antagonists

PHASE1 · PHASE2 · 50 planned enrolment

Countries listed: 1
Registry update: October 5, 2026

Verify in the registry →

RecruitingNCT05327023

Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies

PHASE1 · PHASE2 · 430 planned enrolment

Countries listed: 1
Registry update: September 18, 2026

Verify in the registry →

Enrolling By InvitationNCT07113743

Part B- G1X-CGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous Disease

PHASE1 · PHASE2 · 10 planned enrolment

Countries listed: 1
Registry update: September 8, 2026

Verify in the registry →